Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 352

2.

Universal varicella vaccination: efficacy trends and effect on herpes zoster.

Goldman GS.

Int J Toxicol. 2005 Jul-Aug;24(4):205-13.

PMID:
16126614
3.

Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.

Goldman GS, King PG.

Hum Exp Toxicol. 2014 Aug;33(8):886-93. doi: 10.1177/0960327113512340. Epub 2013 Nov 25.

4.

The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.

van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ.

Vaccine. 2012 Feb 1;30(6):1225-34. doi: 10.1016/j.vaccine.2011.11.026. Epub 2011 Nov 23.

PMID:
22119592
5.

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.

Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, Lewis E, Fireman B, Saddier P.

Pediatrics. 2013 May;131(5):e1389-96. doi: 10.1542/peds.2012-3303. Epub 2013 Apr 1.

6.

Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1766-76. doi: 10.1080/21645515.2015.1135279. Epub 2016 Feb 2.

7.

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.

van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F, Sanders E, de Melker H, van Boven M.

EBioMedicine. 2015 Aug 8;2(10):1494-9. doi: 10.1016/j.ebiom.2015.08.017. eCollection 2015 Oct.

8.

Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?

Bilcke J, van Hoek AJ, Beutels P.

Hum Vaccin Immunother. 2013 Apr;9(4):812-22. doi: 10.4161/hv.23334. Epub 2013 Jan 15.

9.

Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.

van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N.

Vaccine. 2011 Mar 16;29(13):2411-20. doi: 10.1016/j.vaccine.2011.01.037. Epub 2011 Jan 28.

PMID:
21277405
10.

The case against universal varicella vaccination.

Goldman GS.

Int J Toxicol. 2006 Sep-Oct;25(5):313-7.

PMID:
16940003
11.

One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?

Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL.

Pediatrics. 2006 Jun;117(6):e1070-7.

PMID:
16740809
12.

Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.

Littlewood KJ, Ouwens MJ, Sauboin C, Tehard B, Alain S, Denis F.

Clin Ther. 2015 Apr 1;37(4):830-841.e7. doi: 10.1016/j.clinthera.2015.01.006. Epub 2015 Feb 24.

14.

Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.

Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M.

J Infect Dis. 2013 Dec 1;208(11):1859-68. doi: 10.1093/infdis/jit405. Epub 2013 Aug 6.

PMID:
23922376
15.

The effect of vaccination on the epidemiology of varicella zoster virus.

Edmunds WJ, Brisson M.

J Infect. 2002 May;44(4):211-9. Review.

PMID:
12099726
16.

The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.

Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF.

Pediatr Infect Dis J. 2009 Nov;28(11):954-9. doi: 10.1097/INF.0b013e3181a90b16.

PMID:
19536039
17.

Varicella vaccination in England and Wales: cost-utility analysis.

Brisson M, Edmunds WJ.

Arch Dis Child. 2003 Oct;88(10):862-9.

18.

The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.

Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. Review.

PMID:
18419401
19.

Epidemiologic effects of varicella vaccination.

Halloran ME.

Infect Dis Clin North Am. 1996 Sep;10(3):631-55. Review.

PMID:
8856357
20.

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O.

BMC Public Health. 2015 Jun 5;15:533. doi: 10.1186/s12889-015-1861-8. Review.

Supplemental Content

Support Center